ReviewFrontiers in medicine2022

COVID-19 and the potential of Janus family kinase (JAK) pathway inhibition: A novel treatment strategy.

Mansoor Khaledi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.